Speaker illustration

Professor Lars Soendergaard

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

Graduate in 1988 from University of Copenhagen. Trained in cardiology at Rigshospitalet in Copenhagen, as well as Great Ormond Street Hospital for Sick Children and The Heart Hospital in London. Special interest in congenital and structural heart diseases, particular interventional procedures, and Head of these programs at Rigshospitalet in Copenhagen. Led the first-in-human transcatheter mitral valve implantation (CardiAQ) in 2012. Professor of Cardiology at University of Copenhagen. Published 338 peer reviewed articles, and 16 text book chapters. His research interests are focused on adults with congenital heart diseases and catheter-based heart valve interventions. Lead principal investigator for several trials including NOTION (transcatheter vs. surgical aortic valve replacement in patients with aortic stenosis and low surgical risk), and the REDUCE randomised trial (PFO vs anti-platelet therapy after cryptogenic stroke).

TAVI in bicuspid aortic valves: a challenge

Event: ESC Congress 2021 - The Digital Experience

Topic: Valvular Heart Disease

Session type: Symposium

Thumbnail

Late Breaking TAVI Registries

Event: ESC Congress 2018

Topic: Aortic Valve Intervention

Session type: Late-Breaking Science

Thumbnail

Open questions in percutaneous pulmonary valve implantation

Event: ESC CONGRESS 2016

Topic: Grown-up congenital heart disease and surgery

Session type: Case-Based Symposium

Thumbnail

ESC 365 is supported by

logo Novo Nordisk